159 related articles for article (PubMed ID: 31973534)
1. Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells.
Vilotic A; Bojic-Trbojevic Z; Vicovac L; Jovanovic Krivokuca M
Neoplasma; 2020 Mar; 67(2):323-332. PubMed ID: 31973534
[TBL] [Abstract][Full Text] [Related]
2. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness.
Jovanović Krivokuća M; Stefanoska I; Abu Rabi T; Al-Abed Y; Stošić-Grujičić S; Vićovac Lj
Placenta; 2015 Feb; 36(2):150-9. PubMed ID: 25530499
[TBL] [Abstract][Full Text] [Related]
4. Role of the Macrophage Migration Inhibitory Factor (MIF) in the survival of first trimester human placenta under induced stress conditions.
Ietta F; Ferro EAV; Bevilacqua E; Benincasa L; Maioli E; Paulesu L
Sci Rep; 2018 Aug; 8(1):12150. PubMed ID: 30108299
[TBL] [Abstract][Full Text] [Related]
5. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
[TBL] [Abstract][Full Text] [Related]
6. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
[TBL] [Abstract][Full Text] [Related]
7. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
8. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.
Lourenco S; Teixeira VH; Kalber T; Jose RJ; Floto RA; Janes SM
J Immunol; 2015 Apr; 194(7):3463-74. PubMed ID: 25712213
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
12. Trophoblast-like human choriocarcinoma cells serve as a suitable in vitro model for selective cholesteryl ester uptake from high density lipoproteins.
Wadsack C; Hrzenjak A; Hammer A; Hirschmugl B; Levak-Frank S; Desoye G; Sattler W; Malle E
Eur J Biochem; 2003 Feb; 270(3):451-62. PubMed ID: 12542695
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling.
Cheng WL; Kao YH; Chen YC; Lin YK; Chen SA; Chen YJ
Transl Res; 2020 Feb; 216():43-56. PubMed ID: 31669150
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor in human early pregnancy events and association with placental pathologies.
Jovanović Krivokuća M; Vilotić A; Stefanoska I; Bojić-Trbojević Ž; Vićovac L
Placenta; 2021 Dec; 116():51-57. PubMed ID: 33612316
[TBL] [Abstract][Full Text] [Related]
15. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
[TBL] [Abstract][Full Text] [Related]
16. Expression of MIF and CD74 in leukemic cell lines: correlation to DR expression destiny.
Georgouli M; Papadimitriou L; Glymenaki M; Patsaki V; Athanassakis I
Biol Chem; 2016 Jun; 397(6):519-28. PubMed ID: 26866879
[TBL] [Abstract][Full Text] [Related]
17. Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Meza-Romero R; Benedek G; Leng L; Bucala R; Vandenbark AA
Metab Brain Dis; 2016 Apr; 31(2):249-55. PubMed ID: 26851955
[TBL] [Abstract][Full Text] [Related]
18. Serum Levels of Migration Inhibitory Factor (MIF) and
Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
Front Immunol; 2018; 9():246. PubMed ID: 29487601
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.
Hsieh CY; Chen CL; Lin YS; Yeh TM; Tsai TT; Hong MY; Lin CF
J Immunol; 2014 Oct; 193(7):3693-703. PubMed ID: 25172501
[TBL] [Abstract][Full Text] [Related]
20. CD74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
